Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...
News
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...
InMed Announces Appointment of Chief Operating Officer
VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...
VitalHub Announces Multi Year Contract with Buckinghamshire, Oxfordshire and Berkshire Integrated Care System
TORONTO, July 18, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a...
EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update
- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet...
Small Pharma Reports Fiscal First Quarter 2023 Highlights
Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15,...
Agra Ventures Announces Resignation of Brian O’Neill as Director
VANCOUVER, British Columbia, July 15, 2022 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTC: AGFAF)...
Aeterna Zentaris Announces Shareholder Approval of Share Consolidation
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...
Tiziana Life Sciences Announces Resignation of CEO
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...
BC Court of Appeal strengthens landmark ruling defending public health care in Canada
OTTAWA, July 15, 2022 (GLOBE NEWSWIRE) -- Today’s ruling from the BC Court of Appeal in the Cambie Surgeries Corporation...
U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic
Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a...
Bicycle Health to Partner with Aletheia House in Alabama to Ensure Patients Can Continue Treatment for Opioid Use Disorder
BOSTON, July 15, 2022 (GLOBE NEWSWIRE) -- This week, with support from community partners at Aletheia House, Bicycle Health flew...
Sienna Announces July Dividend
MARKHAM, Ontario, July 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
Notice of extraordinary general meeting in Saniona AB
PRESS RELEASE 15 July 2022 The English text is an unofficial translation. In case of any discrepancies between the Swedish...
NYMOX Updates Shareholders
IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders...
New Data Shows Teladoc Health’s Integrated Chronic Care Solutions Deliver Improved Health Outcomes
Latest clinical data underscores the value and impact of whole person care Member Satisfaction Members who use multiple chronic condition...
Adverum Biotechnologies Presents Best-Corrected Visual Acuity and Central Subfield Thickness Analyses After a Single IVT Injection of ADVM-022 (Ixo-vec) in the OPTIC Study in Wet AMD
- Study participants had an 81%-98% reduction in annualized anti-VEGF injections and demonstrated continuous aflibercept expression levels through three years...
Quoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and Supply Agreements
Endo affiliate, Paladin Labs, will commercialize Quoin’s lead asset for Netherton Syndrome in CanadaASHBURN, Va., July 15, 2022 (GLOBE NEWSWIRE)...
CENTOGENE Reports First Quarter 2022 Financial Results
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business...